Gatunan, Rijel Jhon D.

HRN: 11-41-47  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/07/2023
CEFTRIAXONE 1G (VIAL)
07/07/2023
07/13/2023
IV
2g
OD
Acute Pyelonephritis
Waiting Final Action 
07/08/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/08/2023
07/14/2023
IV
500mg
Q8
Amoebiasis Infection
Waiting Final Action 
07/07/2023
METRONIDAZOLE 500MG (TAB)
07/08/2023
07/14/2023
PO
500mg
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: